Increase in systemic resistance leading to hypertension is due to vasoconstrictor effects of erythropoietin on small resistance vessels as studied by Heidenreich et al. in isolated renal and mesenteric vasculature of male rats [13]. Here, EPO is linked to hypertensive disorder.